Whether you're one of the 2.2 million Americans living with epilepsy, or have friends or family affected by the neurological disorder, a new app serves as an excellent resource for your iPhone, iPad or iPod touch.
Called E-Action Info, this free App Store download provides medical info, media and an educational game -- all designed to teach about epilepsy in a clear, accessible manner.
For those living with epilepsy, the app covers management tips, a FAQ (Frequently Asked Questions) section, an interactive and color-coded 3D model of the brain (zoom and rotate to learn about all of its areas and functions), links to epilepsy associations and the option to start a journal, called MyEpilepsyDiary, to help keep an accurate account of when seizures happen.
Be aware, however, this diary feature links to a login page at epilepsy.com [1] opposed to an integrated diary located within the app. While this requires an Internet connection, at least the info is not located on the iOS device itself, which could be a privacy issue if lost, stolen or damaged. Users are encouraged to login with a password to track their seizures, medicines and progress -- all of which are accessible on a computer, smartphone, tablet or other device with a web browser. If desired, users can share this information with their physicians to optimize treatment, plus there's an option to request therapy reminders by email, text or smartphone notification.
E-Action Info was also designed for those close to someone living with epilepsy. For example, along with educational info and a video (Internet connection required), there's a section on the different kinds of seizures and a helpful First Aid resource for caregivers and the public (that is, what to do if you witness someone having a seizure).
While the app was funded by a pharmaceutical company (UCB Pharma SA), there is no mention of the company, its products or even links to its website.
E-Action Info is only available for iOS devices at this point.
Marc Saltzman, Special for USA TODAY3:04p.m. EDT April 9, 2013
No comments:
Post a Comment